Cytokinetics (CYTK) Financials: Revenue & Earnings

CYTK price $60.81 -0.71 -1.15%

Ticker
CYTK
Price
$60.81
Change
-0.71 -1.15%
Market cap ?
$8.45B
P/E ?
-8.42
Forward P/E ?
83.42
Dividend yield ?
0.00%
Beta ?
0.36
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
51
Value
56
Quality
46
Growth
50

Stocklytics score rationale: value 56, quality 46, growth 50.

Financials

2016201720182019202020212022202320242025
10640700013368000315010002686800055828000704280009458800075300001847400088039000

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule…

Fair value

CYTK fair value $28.63. Price $60.81. Price is 112% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare CYTK

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-1.44—41.20M
2026-08-06-1.50-1.6328.62M17.59M
2026-05-05-1.67-1.6719.36M8.52M
2026-02-24-1.50-1.4817.75M6.93M
2025-11-05-2.55-1.591.94M6.05M
2025-08-07-1.12-1.3466.77M2.07M
2025-05-06-1.36-1.411.58M2.79M
2025-02-27-1.26-1.2916.93M14.26M
2024-11-06-1.36-1.27463.00K2.05M
2024-08-08-1.31-1.02249.00K920.00K
2024-05-08-1.33-1.16835.00K900.00K
2024-02-27-1.38-1.031.67M10.77M
2023-11-02-1.35-0.72378.00K11.09M
2023-08-03-1.34-1.23867.00K5.80M
2023-05-04-1.38-1.244.61M2.09M
2023-03-01-1.45-1.221.96M7.10M
2022-11-03-1.28-1.192.52M3.51M
2022-08-04-0.23-1.0488.97M3.73M
2022-05-04-1.02-0.931.15M4.34M
2022-02-24-0.36-0.8955.60M5.80M
2021-11-03-0.95-0.755.44M6.66M
2021-08-05-0.86-0.652.84M2.84M
2021-05-06-0.66-0.596.55M6.82M
2021-02-25-0.62-0.486.72M5.61M
2020-11-04-0.05-0.5941.69M233.04M
2020-08-06-0.68-0.573.59M3.01M
2020-05-06-0.66-0.503.83M2.90M
2020-03-03-0.52-0.425.21M4.41M
2019-10-31-0.50-0.566.05M5.93M
2019-08-08-0.56-0.537.14M6.37M
2019-05-09-0.54-0.478.46M7.37M
2019-02-21-0.48-0.559.38M10.16M
2018-11-01-0.40-0.5310.64M13.57M
2018-07-26-0.51-0.496.21M6.22M
2018-04-26-0.56-0.535.27M4.71M
2018-02-15-0.75-0.7118.00K18.67K
2017-10-26-0.60-0.646.18M6.39M
2017-08-02-0.60-0.663.05M2.90M
2017-04-27-0.62-0.114.15M1.74M
2017-02-160.16-0.2633.14M53.85M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-20Malik Fady IbrahamBuy3.50K$7.8027.30K
2026-10-20Malik Fady IbrahamSell3.50K$64.01224.04K
2026-10-20Malik Fady IbrahamSell3.50K$7.8027.30K
2026-10-16Wysenski NancyBuy97$63.926.20K
2026-10-16Kaye Edward M. MDBuy195$63.9212.46K
2026-10-16Harrington Robert ArthurBuy195$63.9212.46K
2026-10-16Daly James MBuy195$63.9212.46K
2026-10-16WIERENGA WENDELLBuy97$63.926.20K
2026-10-16HENDERSON JOHN TBuy352$63.9222.50K
2026-10-12Blum Robert IBuy7.50K$10.6079.50K
2026-10-12Blum Robert ISell7.50K$62.88471.60K
2026-10-12Blum Robert ISell7.50K$10.6079.50K
2026-10-06Malik Fady IbrahamBuy3.50K$7.8027.30K
2026-10-06Malik Fady IbrahamSell3.50K$61.38214.83K
2026-10-06Malik Fady IbrahamSell3.50K$7.8027.30K
2026-09-28Blum Robert IBuy7.50K$10.6079.50K
2026-09-28Blum Robert ISell7.50K$65.46490.95K
2026-09-28Blum Robert ISell7.50K$10.6079.50K
2026-09-22Malik Fady IbrahamBuy3.50K$7.8027.30K
2026-09-22Malik Fady IbrahamSell3.50K$68.29239.02K
2026-09-22Malik Fady IbrahamSell3.50K$7.8027.30K
2026-09-15Landry Robert ESell1.00K$72.1372.13K
2026-09-15Blum Robert ISell97.93K$69.336.79M
2026-09-14Blum Robert IBuy7.50K$10.6079.50K
2026-09-14Blum Robert ISell7.50K$73.44550.80K
2026-09-14Blum Robert ISell1.35K——
2026-09-14Blum Robert ISell97.93K$69.336.79M
2026-09-14Blum Robert ISell7.50K$10.6079.50K
2026-09-14Blum Robert IBuy97.93K$69.336.79M
2026-09-11Landry Robert ESell1.00K$74.6674.66K
2026-09-08Malik Fady IbrahamBuy3.50K$7.8027.30K
2026-09-08Malik Fady IbrahamSell3.50K$75.46264.11K
2026-09-08Malik Fady IbrahamSell3.50K$7.8027.30K
2026-09-01PARSHALL B LYNNESell5.00K$71.48357.40K
2026-08-31Callos AndrewBuy10.00K$23.26232.60K
2026-08-31Callos AndrewSell10.00K$70.24702.40K
2026-08-31Callos AndrewSell10.00K$23.26232.60K
2026-08-31Blum Robert IBuy7.50K$10.6079.50K
2026-08-31Blum Robert ISell7.50K$70.24526.80K
2026-08-31Blum Robert ISell7.50K$10.6079.50K
2026-08-18Malik Fady IbrahamBuy3.50K$7.8027.30K
2026-08-18Malik Fady IbrahamSell3.50K$75.82265.37K
2026-08-18Malik Fady IbrahamSell3.50K$7.8027.30K
2026-08-10Blum Robert IBuy7.50K$10.6079.50K
2026-08-10Blum Robert ISell7.50K$76.76575.70K
2026-08-10Blum Robert ISell7.50K$10.6079.50K
2026-07-30Callos AndrewBuy14.00K$23.26325.64K
2026-07-30Callos AndrewSell14.00K$79.881.12M
2026-07-30Callos AndrewSell14.00K$23.26325.64K
2026-07-27Blum Robert IBuy7.50K$10.6079.50K
2026-07-27Blum Robert ISell7.50K$80.87606.52K
2026-07-27Blum Robert ISell7.50K$10.6079.50K
2026-07-21Malik Fady IbrahamBuy3.50K$7.8027.30K
2026-07-21Malik Fady IbrahamSell3.50K$80.59282.06K
2026-07-21Malik Fady IbrahamSell3.50K$7.8027.30K
2026-07-15Wysenski NancyBuy75$82.626.20K
2026-07-15WIERENGA WENDELLBuy75$82.626.20K
2026-07-15Kaye Edward M. MDBuy151$82.6212.48K
2026-07-15HENDERSON JOHN TBuy272$82.6222.47K
2026-07-15Harrington Robert ArthurBuy151$82.6212.48K
2026-07-15Daly James MBuy151$82.6212.48K
2026-07-13Blum Robert IBuy7.49K$10.6079.39K
2026-07-13Blum Robert ISell7.49K$82.02614.33K
2026-07-13Blum Robert ISell7.49K$10.6079.39K
2026-07-07Malik Fady IbrahamBuy3.50K$7.8027.30K
2026-07-07Malik Fady IbrahamSell3.50K$86.62303.17K
2026-07-07Malik Fady IbrahamSell3.50K$7.8027.30K
2026-07-01Blum Robert ISell7.50K$84.92636.90K
2026-07-01Callos AndrewBuy15.00K$23.26348.90K
2026-07-01Callos AndrewSell15.00K$85.801.29M
2026-07-01Callos AndrewSell15.00K$23.26348.90K
2026-07-01Lee SungBuy1.11K$48.5153.94K
2026-07-01Lee SungSell1.11K$87.7997.62K
2026-07-01Lee SungSell1.11K$48.5153.94K
2026-06-29Lee SungBuy823$44.3636.51K
2026-06-29Lee SungBuy188$44.368.34K
2026-06-29Lee SungBuy1.11K$48.5153.99K
2026-06-29Lee SungBuy822$44.3636.46K
2026-06-29Lee SungBuy188$44.368.34K
2026-06-29Lee SungSell3.13K$85.00266.39K
2026-06-29Lee SungSell1.11K$48.5153.99K
2026-06-29Lee SungSell822$44.3636.46K
2026-06-29Lee SungSell823$44.3636.51K
2026-06-29Lee SungSell188$44.368.34K
2026-06-29Lee SungSell188$44.368.34K
2026-06-24Lee SungBuy1.11K$48.5153.99K
2026-06-24Lee SungBuy822$44.3636.46K
2026-06-24Lee SungBuy188$44.368.34K
2026-06-24Lee SungBuy1.11K$48.5153.99K
2026-06-24Lee SungBuy2.82K$44.36124.96K
2026-06-24Lee SungBuy9.31K$44.36412.86K
2026-06-24Lee SungBuy23.37K$48.511.13M
2026-06-24Lee SungSell38.73K$82.303.19M
2026-06-24Lee SungSell9.31K$44.36412.86K
2026-06-24Lee SungSell822$44.3636.46K
2026-06-24Lee SungSell23.37K$48.511.13M
2026-06-24Lee SungSell1.11K$48.5153.99K
2026-06-24Lee SungSell1.11K$48.5153.99K
2026-06-24Lee SungSell2.82K$44.36124.96K
2026-06-24Lee SungSell188$44.368.34K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 514, holders +20 vs prior quarter. Ownership 122.61%.

HolderSharesChangeChange %Value
BLACKROCK, INC.20.09M3.55M+21.43%1.71B
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.18.72M1.19M+6.82%1.59B
WELLINGTON MANAGEMENT GROUP LLP6.93M-1.08M-13.46%590.52M
VANGUARD PORTFOLIO MANAGEMENT LLC6.71M868.02K+14.85%571.78M
STATE STREET CORP6.49M749.04K+13.04%553.24M
VANGUARD CAPITAL MANAGEMENT LLC6.12M628.88K+11.46%521.15M
FMR LLC5.03M-5.69M-53.08%428.66M
AVORO CAPITAL ADVISORS LLC5.00M1.67M+50.00%425.95M
BANK OF AMERICA CORP /DE/4.64M1.51M+48.32%394.92M
GEODE CAPITAL MANAGEMENT, LLC3.71M497.09K+15.46%316.33M
RTW INVESTMENTS, LP2.86M140.84K+5.18%243.81M
POLAR CAPITAL HOLDINGS PLC2.25M592.40K+35.66%191.99M
PRICE T ROWE ASSOCIATES INC /MD/1.96M374.62K+23.65%166.88M
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.89M1.56M+474.65%161.06M
GOLDMAN SACHS GROUP INC1.76M1.51M+604.64%150.07M
CAPITAL RESEARCH GLOBAL INVESTORS1.69M915.63K+118.76%143.68M
NORTHERN TRUST CORP1.65M205.71K+14.27%140.34M
JPMORGAN CHASE & CO1.59M685.09K+75.80%139.15M
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC1.60M515.85K+47.43%136.60M
INTEGRAL HEALTH ASSET MANAGEMENT, LLC1.60M600.00K+60.00%136.30M
POINT72 ASSET MANAGEMENT, L.P.1.59M961.61K+153.59%135.26M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.57M1.57MNew133.39M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.57M168.74K+12.08%133.39M
SUSQUEHANNA INTERNATIONAL GROUP, LLP1.55M1.22M+370.96%132.00M
ARMISTICE CAPITAL, LLC1.53M765.46K+100.12%130.34M

Earnings and financials

Cytokinetics, Incorporated (CYTK) trades at $60.81, with a market cap of $8.45B and a trailing P/E of -8.42. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
10640700013368000315010002686800055828000704280009458800075300001847400088039000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Cytokinetics (CYTK) Financials: Revenue & Earnings

CYTK$60.81-0.71 -1.15%

$8.45B

Market Cap

-8.42

P/E

83.42

Forward P/E

51

Score

Price History